个人资料
教育经历工作经历个人简介社会兼职研究方向1. 恶性肿瘤的发病机理和相关基因的讨论‚以及天然化合物对于恶性肿瘤的抑制作用研究。 2. 健康食品作用机理的研究(基因转录和免疫领域)。 3. 血小板信号传导与血栓形成分子机制的研究。 招生与培养开授课程科研项目学术成果1 Hong T‚ Nakagawa T‚ Pan W‚ Kim MY‚ Kraus WL‚ Ikehara T‚ Yasui K‚ Aihara H‚ Takebe M‚ Muramatsu M‚ Ito T. Isoflavones stimulate estrogen receptor-mediated core histone acetylation. Biochem Biophys Res Commun. 2004 Apr 23; 317(1): 259-64.
2 Hong T‚ Shimada Y‚ Uchida S‚ Itami A‚ Li Z‚ Ding Y‚ Kaganoi J‚ Komoto I‚ Sakurai T‚ Imamura M. Expression of angiogenic factors and apoptotic factors in leiomyosarcoma and leiomyoma. Int J Mol Med. 2001 Aug;8(2): 141-8.
3 Hong T‚ Shimada Y‚ Kano M‚ Kaganoi J‚ Uchida S‚ Komoto I‚ Yamabe H‚ Imamura M. The Epstein-Barr virus is rarely associated with esophageal cancer. Int J Mol Med. 2000 Apr; 5(4): 363-8.
4 Ding Y‚ Shimada Y‚ Gorrin-Rivas MJ‚ Itami A‚ Li Z‚ Hong T‚ Maeda M‚ Komoto I‚ Kawabe A‚ Kaganoi J‚ Imamura M. Clinicopathological significance of human macrophage metalloelastase expression in esophageal squamous cell carcinoma. Oncology. 2002; 63(4): 378-84.
5 Li ZG‚ Hong T‚ Shimada Y‚ Komoto I‚ Kawabe A‚ Ding Y‚ Kaganoi J‚ Hashimoto Y‚ Imamura M. Suppression of N-nitrosomethylbenzylamine (NMBA)-induced esophageal tumorigenesis in F344 rats by resveratrol. Carcinogenesis. 2002 Sep; 23(9): 1531-6.
6 Li Z‚ Shimada Y‚ Kawabe A‚ Sato F‚ Maeda M‚ Komoto I‚ Hong T‚ Ding Y‚ Kaganoi J‚ Imamura M. Suppression of N-nitrosomethylbenzylamine (NMBA)-induced esophageal tumorigenesis in F344 rats by JTE-522‚ a selective COX-2 inhibitor. Carcinogenesis. 2001 Apr; 22(4): 547-51.
7 Ding Y‚ Shimada Y‚ Kano M‚ Itami A‚ Kawabe A‚ Maeda M‚ Li Z‚ Hong T‚ Sato F‚ Kaganoi J‚ Imamura M. PTEN/MMAC1 expression in esophageal squamous cell carcinomas. Int J Oncol. 2000 Oct; 17(4): 695-9.
8 Shigeki Uchida‚ Yutaka Shimada‚ Go Watanabe‚ Zhigang Li‚ Tao Hong‚ M Miyake and Masayuki Imamura. Motility-related protein (MRP-1/CD9) and KAI 1/CD82 expression inversely correlate with lymph node metastasis in oesophageal squamous cell carcinoma. British Journal of Cancer. 1999‚ 79: 1168-1173.
荣誉及奖励 |